We reviewed retrospectively 7 Chinese children diagnosed with Wiskott-Aldrich syndrome
(WAS) and managed at the Department of Paediatrics & Adolescent Medicine of Queen …

Abstract Background Wiskott–Aldrich syndrome (WAS) is a rare primary immunodeficiency
disease, with an incidence of 4/1,000,000 live male births. In China, an estimated number of …

Objective Wiskott-Aldrich syndrome (WAS) is a primary immunodeficiency diseases. The
patients with classical WAS have poor prognosis. The hematopoietic stem cell …

Objective: To evaluate the therapeutic efficacy of hematopoietic stem cell transplantation
(HSCT) for Wiskott-Aldrich syndrome (WAS), and to analyze the factors related to the …

We retrospectively analyzed the outcome of bone marrow transplantation (BMT) performed
in 26 patients with Wiskott-Aldrich syndrome (WAS) in one center. Twenty-eight …

We report a novel mutation in a boy with Wiskott–Aldrich syndrome (WAS) who was 4 years
and 10 months of age and underwent successful umbilical cord blood transplantation …

Introduction: Wiskott–Aldrich syndrome (WAS) is characterized by microthrombocytopenia,
eczema, recurrent infections, and an increased incidence of autoimmunity. Commonly …

Wiskott-Aldrich syndrome (WAS) is a rare X-linked disorder characterized by a triad of
immunodeficiency, eczema, and thrombocytopenia. Currently, hematopoietic stem cell …

Abstract The Wiskott-Aldrich Syndrome (WAS) is a rare X-linked immunohematological
disorder characterized by eczema, profound thrombocytopenia, and progressive …

On the basis of a nationwide database of 160 patients with Wiskott-Aldrich syndrome (WAS),
we identified a subset of infants who were significantly more likely to be attributed with an …